Understanding how a protein called LOX-1 helps the body recover from pneumonia
Establishing Mechanisms of LOX-1-Dependent Immune Regulation During Pneumonia
This research explores how a specific protein in the lungs, called LOX-1, helps people recover from pneumonia by reducing inflammation and injury.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-11140382 on NIH RePORTER |
What this research studies
Pneumonia is a serious infection, and recovering fully means both clearing the germs and healing the lung tissue. This project focuses on the healing part, which is not as well understood. We are looking at a protein called LOX-1, which seems to protect the lungs from swelling and inflammation during pneumonia. While LOX-1 is known to cause problems in blood vessels during heart disease, our early findings suggest it plays a helpful role in the lungs. By understanding how LOX-1 works, we hope to find new ways to help patients recover better from pneumonia.
Who could benefit from this research
Good fit: This foundational research is relevant for patients who have experienced pneumonia, especially those with severe forms like Acute Respiratory Distress Syndrome (ARDS).
Not a fit: Patients without pneumonia or related acute lung injuries would not directly benefit from this specific research at this stage.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that help patients recover more effectively from pneumonia and prevent severe lung damage.
How similar studies have performed: While LOX-1's role in heart disease is established, its protective function in the lung during pneumonia is a novel finding suggested by the researchers' preliminary data.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Korkmaz, Filiz — University of Iowa
- Study coordinator: Korkmaz, Filiz
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.